218 related articles for article (PubMed ID: 9382798)
1. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
Liu KD; Gaffen SL; Goldsmith MA; Greene WC
Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
[TBL] [Abstract][Full Text] [Related]
2. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
[TBL] [Abstract][Full Text] [Related]
3. JAK1 Pseudokinase V666G Mutant Dominantly Impairs JAK3 Phosphorylation and IL-2 Signaling.
Grant AH; Rodriguez AC; Rodriguez Moncivais OJ; Sun S; Li L; Mohl JE; Leung MY; Kirken RA; Rodriguez G
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047778
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.
Lee IH; Li WP; Hisert KB; Ivashkiv LB
J Exp Med; 1999 Nov; 190(9):1263-74. PubMed ID: 10544198
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases.
Roskoski R
Pharmacol Res; 2016 Sep; 111():784-803. PubMed ID: 27473820
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.
Ruiz-Medina BE; Ross JA; Kirken RA
J Biol Chem; 2015 Aug; 290(34):20972-20983. PubMed ID: 26152718
[TBL] [Abstract][Full Text] [Related]
7. A novel intramolecular negative regulation of mouse Jak3 activity by tyrosine 820.
Sekine Y; Kikkawa K; Witthuhn BA; Kashiwakura JI; Muromoto R; Kitai Y; Fujimuro M; Oritani K; Matsuda T
Int Immunol; 2022 Jun; 34(6):303-312. PubMed ID: 35192696
[TBL] [Abstract][Full Text] [Related]
8. JAK3 Y841 Autophosphorylation Is Critical for STAT5B Activation, Kinase Domain Stability and Dimer Formation.
Rodriguez G; Martinez GS; Negrete OD; Sun S; Guo W; Xie Y; Li L; Xiao C; Ross JA; Kirken RA
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569303
[TBL] [Abstract][Full Text] [Related]
9. Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain.
Raivola J; Hammarén HM; Virtanen AT; Bulleeraz V; Ward AC; Silvennoinen O
Front Oncol; 2018; 8():560. PubMed ID: 30560087
[TBL] [Abstract][Full Text] [Related]
10. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.
Degryse S; de Bock CE; Cox L; Demeyer S; Gielen O; Mentens N; Jacobs K; Geerdens E; Gianfelici V; Hulselmans G; Fiers M; Aerts S; Meijerink JP; Tousseyn T; Cools J
Blood; 2014 Nov; 124(20):3092-100. PubMed ID: 25193870
[TBL] [Abstract][Full Text] [Related]
11. Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors.
Springuel L; Hornakova T; Losdyck E; Lambert F; Leroy E; Constantinescu SN; Flex E; Tartaglia M; Knoops L; Renauld JC
Blood; 2014 Dec; 124(26):3924-31. PubMed ID: 25352124
[TBL] [Abstract][Full Text] [Related]
12. Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling.
Smith GA; Uchida K; Weiss A; Taunton J
Nat Chem Biol; 2016 May; 12(5):373-9. PubMed ID: 27018889
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain.
Tokarski JS; Zupa-Fernandez A; Tredup JA; Pike K; Chang C; Xie D; Cheng L; Pedicord D; Muckelbauer J; Johnson SR; Wu S; Edavettal SC; Hong Y; Witmer MR; Elkin LL; Blat Y; Pitts WJ; Weinstein DS; Burke JR
J Biol Chem; 2015 Apr; 290(17):11061-74. PubMed ID: 25762719
[TBL] [Abstract][Full Text] [Related]
14. Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling.
Raivola J; Haikarainen T; Silvennoinen O
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31892268
[TBL] [Abstract][Full Text] [Related]
15. Excreted-secreted antigens of Toxoplasma gondii inhibit Foxp3 via IL-2Rγ/JAK3/Stats pathway.
Chen J; Huang C; Zhu D; Chen L; Wang J; Sun X; Hu L; Duan Y
J Cell Biochem; 2018 Dec; 119(12):10176-10185. PubMed ID: 30129110
[TBL] [Abstract][Full Text] [Related]
16. Role of the JAK/STAT pathway in a streptozotocin-induced diabetic retinopathy mouse model.
Cho CH; Roh KH; Lim NY; Park SJ; Park S; Kim HW
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3553-3563. PubMed ID: 35599279
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling.
Rutherford C; Speirs C; Williams JJ; Ewart MA; Mancini SJ; Hawley SA; Delles C; Viollet B; Costa-Pereira AP; Baillie GS; Salt IP; Palmer TM
Sci Signal; 2016 Nov; 9(453):ra109. PubMed ID: 27919027
[TBL] [Abstract][Full Text] [Related]
18. Janus Kinase 3 phosphorylation and the JAK/STAT pathway are positively modulated by follicle-stimulating hormone (FSH) in bovine granulosa cells.
Zareifard A; Beaudry F; Ndiaye K
BMC Mol Cell Biol; 2023 Jun; 24(1):21. PubMed ID: 37337185
[TBL] [Abstract][Full Text] [Related]
19. JAK1: Number one in the family; number one in inflammation?
Spinelli FR; Colbert RA; Gadina M
Rheumatology (Oxford); 2021 May; 60(Suppl 2):ii3-ii10. PubMed ID: 33950229
[TBL] [Abstract][Full Text] [Related]
20. JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway.
Wang W; Li F; Xu Y; Wei J; Zhang Y; Yang H; Gao B; Yu G; Fang D
J Biol Chem; 2018 Jul; 293(28):11067-11075. PubMed ID: 29789426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
